Case Reports in Nephrology · 2016 · 10 citations · 8 references
MedicinePharmacologyPharmacotherapyAutoimmunityImmunopathologyInflammationGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory Disease PharmacotherapyInterstitial NephritisRenal InflammationTubulointerstitial DiseasesAutoimmune Tubulointerstitial NephritisChronic Interstitial NephritisChronic Tubulointerstitial NephritisDrug-induced Tubulointerstitial NephritisInflammatory Bowel Disease ImmunopathogenesisInflammatory Bowel Disease PathologyNonsteroidal Anti-inflammatory Drug - Induced Interstitial NephritisTubulointerstitial Nephritis Syndrome
Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil might be an effective alternative. We report a patient who responded well to mycophenolate despite continuing mesalamine, the suspected offending agent.
8